Niacin Can Raise HDL Without Preventing More Cardiovascular Events on Statin Therapy
A guide to AIM-HIGH and HPS2-THRIVE, showing why better lipid numbers did not translate into better outcomes and why side effects matter.
A guide to AIM-HIGH and HPS2-THRIVE, showing why better lipid numbers did not translate into better outcomes and why side effects matter.
Compare VITAL and D-Health findings on vitamin D supplements and cardiovascular events without turning mixed trial results into prevention claims.
Why antioxidant mechanisms and observational studies did not translate into cardiovascular prevention in major vitamin E trials.
Examine CoQ10 claims about statin muscle symptoms, the gap between biological explanations and trial results, and medicine interaction questions.
Learn how to compare fish oil labels, serving sizes, EPA and DHA amounts, extra vitamins, and clinical claims without confusing oil weight with active content.
Review garlic supplement evidence, modest cholesterol effects, formulation differences, bleeding concerns, and the distinction between food and concentrated products.
Understand why glucosamine and chondroitin belong on a medication list, how mixed joint formulas complicate reviews, and what to bring to a pharmacist.
Understand magnesium blood pressure research, the meaning of a qualified health claim, elemental amounts, and why food patterns differ from supplement trials.
Distinguish nutritional gap coverage from cardiovascular prevention claims using multivitamin research, trial outcomes, and label considerations.
Understand EPA, DHA, fish oil labels, cardiovascular research, and why prescription omega-3 studies do not automatically apply to every supplement.
Explore plant sterol claims, LDL changes, food and supplement differences, study context, and why a biomarker result should be reported precisely.
Learn why potassium-containing salt substitutes and supplements require attention to kidney function, medicines, serving amounts, and individual guidance.